8,8-dimethyl-5-nonenoic acid | 84565-08-2

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 脂肪酰基
• 英文名称: 8,8-dimethyl-5-nonenoic acid
• 英文别名: (E)-8,8-dimethylnon-5-enoic acid
• CAS: 84565-08-2
• 化学式: C₁₁H₂₀O₂
• 分子量: 184.279
• InChiKey: XOOYVDZQPOREOF-FNORWQNLSA-N

物化性质

• 沸点：
  282.1±9.0 °C(Predicted)
• 密度：
  0.928±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  3
• 重原子数：
  13
• 可旋转键数：
  6
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.73
• 拓扑面积：
  37.3
• 氢给体数：
  1
• 氢受体数：
  2

反应信息

• 作为产物：
  描述：

  5-氧代戊酸甲酯 在 copper(l) iodide 作用下， 以 四氢呋喃 为溶剂， 反应 1.0h， 生成 8,8-dimethyl-5-nonenoic acid
  参考文献：
  名称：

  Simple methods for the syntheses of (E)-4- and (E)-5-alkenoic acids by the SN2′ type reactions of γ-vinyl-γ-butyrolactone and δ-vinyl-δ-valerolactone with organocopper reagents

  摘要：

  DOI：

  10.1016/s0040-4039(00)87676-5

文献信息

• Regio- and Stereoselective Ring Opening of ω-Alkenyllactones Using Organocopper Reagents
  作者：Masatoshi Kawashima、Toshio Sato、Tamotsu Fujisawa

  DOI：10.1246/bcsj.61.3255

  日期：1988.9

  by the regio- and stereoselective ring opening of β, γ, and δ-lactones with unsaturated substituents at the ω-position using organocopper reagents such as halomagnesium diorganocuprates or Grignard reagents in the presence of copper(I) iodide. Both the organocopper reagents with primary, secondary, tertiary alkyl, and phenyl groups gave the corresponding carbon homologated alkenoic acids in good yields

  描述了通过 β、γ 和 δ-内酯的区域和立体选择性开环来制备 (E)-3-、(E)-4- 和 (E)-5- 烯酸的新合成方法在碘化铜 (I) 存在下，使用有机铜试剂如卤化二有机铜酸盐或格氏试剂在 ω 位去除不饱和取代基。具有伯、仲、叔烷基和苯基的有机铜试剂均以良好的产率得到相应的碳同系链烯酸。通过 ω-烯基内酯与二乙烯基-和二烯丙基铜酸盐的反应，也以良好的产率获得链二烯酸。利用β-异丙烯基-β-丙内酯的开环，很容易以良好的收率获得高萜类羧酸。
• FUJISAWA, TAMOTSU;SATO, TOSHIO;KAWASHIMA, MASATOSHI;NARUSE, KOUICHI;TAMAI+, TETRAHEDRON LETT., 1982, 23, N 35, 3583-3586
  作者：FUJISAWA, TAMOTSU、SATO, TOSHIO、KAWASHIMA, MASATOSHI、NARUSE, KOUICHI、TAMAI+

  DOI：——

  日期：——
• Methods for identifying and using IKK inhibitors
  申请人：Karin Michael

  公开号：US20090054524A1

  公开（公告）日：2009-02-26

  The present invention provides methods and compositions for inhibiting IKK, as well as methods and compositions for identifying compounds with activity as inhibitors of IKK, and methods and compositions for the treatment of diseases and/or conditions wherein IKK is implicated and inhibition of its activity is desired. In addition, the present invention provides methods and compositions for the improving the therapeutic activity of COX2 inhibitors, comprising administering the COX2 to a subject in combination with a compound that inhibits IKK activity. The present invention further provides compositions that comprise compounds that inhibit IKK and COX2.
• Simple methods for the syntheses of (E)-4- and (E)-5-alkenoic acids by the SN2′ type reactions of γ-vinyl-γ-butyrolactone and δ-vinyl-δ-valerolactone with organocopper reagents
  作者：Tamotsu Fujisawa、Toshio Sato、Masatoshi Kawashima、Kouichi Naruse、Kouichi Tamai

  DOI：10.1016/s0040-4039(00)87676-5

  日期：1982.1